A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies

NCT01476657 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
210
Enrollment
INDUSTRY
Sponsor class

Stopped The scope of the program has been reduced to focus resources on studies which can potentially enable the registration of duvelisib.

Conditions

Interventions

Sponsor

SecuraBio